Results 141 to 150 of about 1,002 (150)

Human CYP1A1 variants lead to differential eicosapentaenoic acid metabolite patterns

Biochemical and Biophysical Research Communications, 2005
Wolf-Hagen Schunck, Ivar Roots, Dieter Schwarz   +2 more
exaly  

Methysticin and 7,8-Dihydromethysticin are Two Major Kavalactones in Kava Extract to Induce CYP1A1

Toxicological Sciences, 2011
Hu Mei, Leming Shi, Qiangen Wu
exaly  

Furanoflavones pongapin and lanceolatin B blocks the cell cycle and induce senescence in CYP1A1-overexpressing breast cancer cells

Bioorganic and Medicinal Chemistry, 2018
Sandip B Bharate, Ibidapo Williams, Bob Chaudhuri   +2 more
exaly  

The effect of synthetic glucocorticoid, dexamethasone on CYP1A1 inducibility in adult rat and human hepatocytes

FEBS Letters, 2005
Russell Prough, Katalin Monostory
exaly  

DNA methylation of the CYP1A1 enhancer is associated with smoking‐induced genetic alterations in human lung

International Journal of Cancer, 2012
Shan Zienolddiny-Narui, Xavier Tekpli, Steen Mollerup   +2 more
exaly  

CYP1A1

openaire   +1 more source

The flavonoid galangin is an inhibitor of CYP1A1 activity and an agonist/antagonist of the aryl hydrocarbon receptor

British Journal of Cancer, 1999
G C Yeh, H P Ciolino
exaly  

Expression of CYP1A1 in livers and gonads of Pacific salmon: quantitation of mRNA levels by RT-cPCR

Aquatic Toxicology, 1996
exaly  

Association between CYP1A1 polymorphism and colorectal cancer risk: a meta-analysis

Molecular Biology Reports, 2011
exaly  

CYP1A1 * 2B and * 4 Polymorphisms are associated with Lung Cancer Susceptibility in Mexican Patients

International Journal of Biological Markers, 2008
exaly